Dual-energy computed tomography parameters for the differentiation of vertebral small osteolytic metastases (SOMs) and SOM-mimics
Author Block: J. Li1, J. Liu2; 1Fujian/CN, 2Xiamen/CN
Purpose: To evaluate the value of dual energy computed tomography (DECT) quantitative parameters for the differentiation of small osteolytic metastases (SOMs) and SOM-mimics such as osteopenia, osteoporosis, and Schmorl's nodule.
Methods or Background: Fat(HAP), fat(calcium), hydroxyapatite(fat), and calcium(fat) densities [Dfat(HAP), Dfat(calcium), DHAP(fat), and Dcalcium(fat)], as well as CT value were collected. Comparisons were made using the independent sample T test. Diagnostic performance was assessed in terms of area under the receiver operating characteristic curve (AUC). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of each parameter was assessed as well.
Results or Findings: A total of 106 patients were included, of whom 24 had SOMs (lesion, n = 48), while 82 had SOM-mimics (lesion, n = 202). SOMs associated with significantly higher CT value, Dfat(calcium), and Dfat(HAP) compared to SOM-mimics (P < .001). The AUCs were 0.674, 0.879, and 0.887, respectively. The sensitivity, specificity, PPV, NPV, and accuracy of fat(calcium) were 77.1%, 85.1%, 55.2%, 94.0%, 83.6%, respectively; while those for Dfat(HAP) were 83.3%, 80.7%, 50.6%, 95.3%, 81.2%, respectively. The optimal diagnostic cutoffs for Dfat(calcium) and Dfat(HAP) were ≥ 1000.0 mg/cm3 and ≥ 966.9 mg/cm3, respectively, which achieved consistent diagnostic results among 89.6% lesions (n = 224). The combined use of Dfat(HAP) and Dfat(calcium) achieved significantly better diagnostic performance, with AUC, sensitivity, specificity, PPV, NPV, and accuracy of 0.910, 82.2%, 87.2%, 61.7%, 95.1%, and 86.2%, respectively.
Conclusion: Dfat(calcium) and Dfat(HAP) on DECT carry the potential as parameters for the discrimination of SOMs from SOM-mimics
Limitations: This was a retrospective study with a relatively small sample size. In addition, the focus on thoracolumbar lesions limits the generalizability of our results.
Funding for this study: Natural Science Foundation of Fujian Province, China (grant numbers: 2023J01181)
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: Fujian Cancer Hospital Ethics Committee (K2023-198-01)